Keyphrases
Methyl
100%
Phenyl
100%
Monkey
100%
Frontal Cognitive Impairment
100%
1,2,3,6-Tetrahydropyridine
100%
Dopaminergic Therapy
40%
Reaction Time
20%
Saccades
20%
Oculomotor
20%
Dopaminergic Neurons
20%
Movement Time
20%
Perseverative Errors
20%
Behavior Change
10%
No Response
10%
Differential Effects
10%
Neuronal Activity
10%
Placebo
10%
Cognitive Deficits
10%
Frontal Cortex
10%
Patients with Parkinson's Disease
10%
Frontal Lobe Epilepsy
10%
Midbrain
10%
Primate Model
10%
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
10%
Self-initiated
10%
Saccadic Eye Movements
10%
Gross Motor
10%
Motor Symptoms
10%
Parkinsonism
10%
Motor Disorders
10%
Behavioral Modes
10%
Omission Error
10%
Rhesus Monkey
10%
Early Release
10%
Substantia Nigra Pars Compacta
10%
Response Location
10%
Tyrosine Hydroxylase Immunohistochemistry
10%
Delayed Response Task
10%
Cognitive Disorders
10%
Location Error
10%
Eye Pattern
10%
Parkinsonian Signs
10%
Neuroscience
Cognitive Disorders
100%
Tetrahydropyridine
100%
Dopaminergic
36%
Frontal Lobe
18%
Saccade
18%
Dopaminergic Neuron
18%
Neuronal Activity
9%
Parkinson's Disease
9%
Eye Movement
9%
Midbrain
9%
Tyrosine Hydroxylase
9%
Substantia Nigra Pars Compacta
9%
Stereotypic Movement Disorder
9%
Parkinsonism
9%
Placebo
9%
Immunohistochemistry
9%